On 2025-05-07, Barinthus Biotherapeutics PLC Sponsored ADR (BRNS) announced earnings per share of $-0.49 for the fiscal quarter ending 2025-03-31, missing the average analyst estimate of $-0.34.
The next expected annoucement date for quarterly earnings is 2025-08-14, with an average estimated earnings per share of $-0.33 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-05-07 | 2025-03-31 | $-0.34 | $-0.49 |
| 2025-03-20 | 2024-12-31 | $-0.35 | $-0.51 |
| 2024-11-06 | 2024-09-30 | $-0.45 | $-0.21 |
| 2024-08-08 | 2024-06-30 | $-0.42 | $-0.43 |
| 2024-05-13 | 2024-03-31 | $-0.64 | $-0.40 |
| 2024-03-20 | 2023-12-31 | $-0.55 | $-0.45 |
| 2023-11-09 | 2023-09-30 | $-0.62 | $-0.37 |
| 2023-08-10 | 2023-06-30 | $-0.59 | $-0.62 |
| 2023-05-12 | 2023-03-31 | $-0.58 | $-0.48 |
| 2023-03-24 | 2022-12-31 | $-0.43 | $-0.55 |
| 2022-11-10 | 2022-09-30 | $-0.32 | $0.22 |
| 2022-08-09 | 2022-06-30 | $-0.41 | $0.41 |
| 2022-05-11 | 2022-03-31 | $-0.32 | $0.07 |
| 2022-03-25 | 2021-12-31 | $-0.36 | $-0.38 |
| 2021-11-12 | 2021-09-30 | $-0.50 | $-0.13 |
| 2021-08-12 | 2021-06-30 | $-0.79 | $-0.64 |
| 2021-06-14 | 2021-03-31 | $-1.21 | $-0.96 |